| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.38 | 6e-30 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.45 | 7e-26 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.28 | 3e-15 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.36 | 9e-13 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-11 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-09 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.38 | 1e-08 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.26 | 2e-06 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.32 | 3e-06 |